Despite seeing encouraging results, the New Brunswick woman says she doesn't qualify for a program that helps pay for food ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

For payers, claims for rare disease treatments used to be uncommon. Not anymore, thanks to an increasing number of new, ...

In crisis mode, Ravi asks Nicola for dealer Okie’s number so he can enlist him to do a dodgy job – but is forced to hide his ...

Six years later, the result is “Young Firecrackers,” a five-part memoir written by Rehn and four of his high school friends who survived addiction: Ashley Mercurio, Ryan Bernstein, Andrew Theriot and ...

GLP-1 drugs like Ozempic® and Zepbound®, have gained significant attention in recent years for treating both diabetes and ...

For the first time, scientists have systematically studied the genetic effects of chemotherapy on healthy tissues.

A new nanoparticle capable of carrying much higher doses of drugs while staying stable for extended periods could make ...

Although Gentamicin is already approved by the U.S. Food and Drug Administration (FDA), its use in people is limited. It can ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.